Wessels Gregory S. 4
4 · Aprea Therapeutics, Inc. · Filed Sep 18, 2020
Insider Transaction Report
Form 4
Wessels Gregory S.
SVP, Chief Commercial Officer
Transactions
- Award
Stock Option (right to Buy)
2020-09-16+14,700→ 14,700 totalExercise: $28.75Exp: 2030-09-16→ Common Stock (14,700 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on September 16, 2021, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.